Levoketoconazole: a novel treatment for endogenous Cushing's syndrome

Article

Abstract: Introduction: Endogenous Cushing’s syndrome (CS) is a rare, life-threatening endocrine disorder that

Palabras claves:

cortisol, Cushing’s disease, Cushing’s syndrome, Ketoconazole, levoketoconazole, medical therapy, steroidogenesis inhibitor

Autores:

Biller B.M.K., Fleseriu M., Pivonello R., Richard J. Auchus, Salvatori R., Zacharieva S.

Fuentes:

scopus